H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs INVAGEN PHARMACEUTICALS, INC.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
INVAGEN PHARMACEUTICALS, INC.
NYRank #FEIN 20-1420845

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPINVAGEN PHARMACEUTICALS, INC.
Total filings79,212383
Certified %12.57%23.50%
Denied %0.01%0.00%
Withdrawn %0.04%0.00%
Cert-withdrawn %0.01%1.31%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite statePANY

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Certified99.5%
Cert-withdrawn0.1%
Withdrawn0.3%
Denied0.1%

Outcomes — INVAGEN PHARMACEUTICALS, INC.

DOL case-status mix.

Certified94.7%
Cert-withdrawn5.3%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
INVAGEN PHARMACEUTICALS, INC.

Top 5 occupations — Deloitte Consulting LLP

Top 5 occupations — INVAGEN PHARMACEUTICALS, INC.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.